Overview

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

Status:
Completed

Trial end date:
2020-03-31

Target enrollment:

Participant gender:

Summary

A clinical study to investigate if a single dose of an approved drug product (glycopyrrolate Inhalation Solution) reduces trapped air in the lungs of participants with chronic obstructive pulmonary disease. This study is accepting male and female participants over the age of 40. The study will be conducted at one site located in the United States.

Phase:

Phase 4

Details

Lead Sponsor:

Sunovion Respiratory Development Inc.

Treatments:

Glycopyrrolate
Pharmaceutical Solutions